The EGFR R521K polymorphism influences the risk to develop colorectal cancer.
Martinelli M, Ugolini G, Scapoli L, Rivetti S, Lauriola M, Mattei G, Rosati G, Montroni I, Manaresi A, Zattoni D, Taffurelli M, Solmi R.
Martinelli M, et al.
Cancer Biomark. 2010-2011;8(2):61-5. doi: 10.3233/DMA-2011-0826.
Cancer Biomark. 2010.
PMID: 21896992